These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 17151121

  • 1. Antiviral peptides targeting the west nile virus envelope protein.
    Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E.
    J Virol; 2007 Feb; 81(4):2047-55. PubMed ID: 17151121
    [Abstract] [Full Text] [Related]

  • 2. Antibodies targeting linear determinants of the envelope protein protect mice against West Nile virus.
    Ledizet M, Kar K, Foellmer HG, Bonafé N, Anthony KG, Gould LH, Bushmich SL, Fikrig E, Koski RA.
    J Infect Dis; 2007 Dec 15; 196(12):1741-8. PubMed ID: 18190253
    [Abstract] [Full Text] [Related]

  • 3. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis.
    Desprès P, Combredet C, Frenkiel MP, Lorin C, Brahic M, Tangy F.
    J Infect Dis; 2005 Jan 15; 191(2):207-14. PubMed ID: 15609230
    [Abstract] [Full Text] [Related]

  • 4. Use of RNA interference to prevent lethal murine west nile virus infection.
    Bai F, Wang T, Pal U, Bao F, Gould LH, Fikrig E.
    J Infect Dis; 2005 Apr 01; 191(7):1148-54. PubMed ID: 15747251
    [Abstract] [Full Text] [Related]

  • 5. Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis.
    Purtha WE, Myers N, Mitaksov V, Sitati E, Connolly J, Fremont DH, Hansen TH, Diamond MS.
    Eur J Immunol; 2007 Jul 01; 37(7):1845-54. PubMed ID: 17559174
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Recombinant West Nile virus envelope protein E and domain III expressed in insect larvae protects mice against West Nile disease.
    Alonso-Padilla J, de Oya NJ, Blázquez AB, Escribano-Romero E, Escribano JM, Saiz JC.
    Vaccine; 2011 Feb 17; 29(9):1830-5. PubMed ID: 21211580
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice.
    Wicker JA, Whiteman MC, Beasley DW, Davis CT, Zhang S, Schneider BS, Higgs S, Kinney RM, Barrett AD.
    Virology; 2006 Jun 05; 349(2):245-53. PubMed ID: 16624366
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. West Nile virus neutralization by US plasma-derived immunoglobulin products.
    Planitzer CB, Modrof J, Kreil TR.
    J Infect Dis; 2007 Aug 01; 196(3):435-40. PubMed ID: 17597458
    [Abstract] [Full Text] [Related]

  • 19. Development of peptides targeting receptor binding site of the envelope glycoprotein to contain the West Nile virus infection.
    Mertinková P, Mochnáčová E, Bhide K, Kulkarni A, Tkáčová Z, Hruškovicová J, Bhide M.
    Sci Rep; 2021 Oct 11; 11(1):20131. PubMed ID: 34635758
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.